CEO Brady Granier and CFO Lourdes Felix of BioCorRx, Inc., (OTCQB: BICXD) join host Everett Jolly to talk about details of their NIDA grant application approval, recent reverse stock split, and plans for the development of BICX102.

Alcoholism # Anahiem # implants # independent treatment providers # Naltrexone # out patient programs # pre IND meeting # recovery # support # therapy